title: Preoperative therapeutic plasma exchange in patients with thyrotoxicosis.
abstract: The purpose of this report was to determine the effectiveness of therapeutic plasma exchange (TPE) in preoperative preparation of patients with thyrotoxicosis scheduled for either thyroid or nonthyroid surgery. We retrospectively reviewed 11 patients with thyrotoxicosis and those who prepared surgery with plasmapheresis between 1999 and 2008 at our institution. Ten patients underwent thyroid surgery and one patient was operated for femur fracture during antithyroid drug treatment. The indications for plasmapheresis in all patients with severe thyrotoxicosis were poor response to medical treatment (seven patients), agronulocytosis due to antithyroid drugs (three patients), iodine-induced thyrotoxicosis (Jodd Basedow effect in one patient), and rapid preparation for urgent orthopedic operation (one patient). After TPE, we observed a marked decrease in free thyroxin (FT3) and free triiodothyronin (FT4) levels; however, the decline in the biochemical values were not statically significant (P > 0.62, P > 0.15). Although both FT3 and FT4 levels remained above the normal limits in two of 11 patients, the signs and symptoms of thyrotoxicosis improved in all patients and no thyroid storm observed during the perioperative period. TPE can be considered a safe and effective alternative to prepare patients with thyrotoxicosis for surgery when drug treatment fails or is contraindicated and when emergency surgery is required.
authors.affiliation: Department of General Surgery, Baskent University, Ankara, Turkey.
authors.forename: Ali
authors.initials: A
authors.lastname: Ezer
authors.forename: Kenan
authors.initials: K
authors.lastname: Caliskan
authors.forename: Alper
authors.initials: A
authors.lastname: Parlakgumus
authors.forename: Sedat
authors.initials: S
authors.lastname: Belli
authors.forename: Ilknur
authors.initials: I
authors.lastname: Kozanoglu
authors.forename: Sedat
authors.initials: S
authors.lastname: Yildirim
mesh_terms: D000328:Adult; D000380:Agranulocytosis / Q000097:blood / Q000139:chemically induced / Q000628:therapy; D013956:Antithyroid Agents / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010951:Plasma Exchange; D011300:Preoperative Care / Q000379:methods*; D012189:Retrospective Studies; D013971:Thyrotoxicosis / Q000097:blood / Q000628:therapy*; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood
chemical_list: D013956:Antithyroid Agents; D014284:Triiodothyronine; D013974:Thyroxine